PD-1 Inhibitor 16

Based on 1 reference(s) in Google Scholar 8 10 1

Axon 3694

CAS [2005454-12-4]

MF C14H23N7O6
MW 385.38

  • Purity: 99%
  • Optical purity: 99% e.e.
  • Soluble in Water and DMSO

PD-1 Inhibitor 16

Description

PD-1 Inhibitor 16 (extracted from Patent (compound 16, ref 1)) is an orally bioavailable small molecule peptidomimetic inhibitor of the immune checkpoint regulatory proteins PD-I/PD-L1 (programmed cell death -1/programmed cell death ligand-1) interaction, with signaling activity in cancer cells, and is currently being evaluated as a potential negative immune checkpoint regulatory and antineoplastic agent.

* Sold in collaboration with Chemietek.

KEYWORDS: PD-1 Inhibitor 16 | PD-1 inhibitor | PD1 Inhibitor 16 | PD 1 Inhibitor 16 | CT-PD1-16 | CAS [2005454-12-4] | T-Cell activity | PD-1 | Inhibitor | Proteins

PD-1 inhibitor

Chemical name

(2S,3S)-2-(3-((S)-3-amino-3-oxo-1-(3-(piperazin-1-yl)-1,2,4-oxadiazol-5-yl)propyl)ureido)-3-hydroxybutanoic acid

Source information

Sold in collaboration with Chemietek

Parent CAS No.

[2005454-12-4]

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...